HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alan Menter Selected Research

calcipotriene (calcipotriol)

10/2020Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5-15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials.
6/2017Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.
1/2017Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.
1/2017Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam Is Well Tolerated in Patients with Psoriasis Vulgaris: Pooled Data from Three Randomized Controlled Studies.
1/2017Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.
8/2016Aerosol Foam Formulation of Fixed Combination Calcipotriene Plus Betamethasone Dipropionate is Highly Efficacious in Patients With Psoriasis Vulgaris: Pooled Data From Three Randomized Controlled Studies.
1/2013Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
1/2009Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alan Menter Research Topics

Disease

167Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 01/2002
17Psoriatic Arthritis
06/2016 - 09/2003
9Neoplasms (Cancer)
06/2020 - 03/2004
9Infections
09/2015 - 10/2004
6Inflammation (Inflammations)
04/2021 - 01/2018
6Pain (Aches)
02/2020 - 01/2007
6Skin Diseases (Skin Disease)
10/2016 - 10/2004
4Atopic Dermatitis (Atopic Eczema)
09/2020 - 02/2015
4Erythema
02/2020 - 03/2004
4Pruritus (Itching)
01/2017 - 12/2003
4Skin Neoplasms (Skin Cancer)
09/2015 - 01/2006
3Multiple Sclerosis
06/2020 - 04/2010
3Nasopharyngitis
01/2017 - 03/2012
3Basal Cell Carcinoma (Rodent Ulcer)
01/2017 - 01/2006
3Melanoma (Melanoma, Malignant)
10/2016 - 01/2006
3Acne Vulgaris
06/2007 - 03/2004
2Latent Tuberculosis
06/2020 - 07/2009
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 06/2008
2Insulin Resistance
01/2020 - 01/2018
2Hypercalcemia (Milk Alkali Syndrome)
04/2018 - 01/2010
2Drug-Related Side Effects and Adverse Reactions
01/2017 - 12/2008
2Body Weight (Weight, Body)
01/2017 - 10/2015
2Neutropenia
10/2015 - 03/2012
2Cardiovascular Diseases (Cardiovascular Disease)
12/2014 - 07/2009
2Progressive Multifocal Leukoencephalopathy
06/2014 - 10/2009
2Rosacea (Acne Rosacea)
06/2010 - 03/2004
2Autoimmune Diseases (Autoimmune Disease)
04/2010 - 03/2008
2Crohn Disease (Crohn's Disease)
04/2010 - 01/2010
2Rheumatoid Arthritis
01/2010 - 03/2008
2Actinic Keratosis
06/2008 - 08/2002
2Atrophy
11/2007 - 03/2004
2Telangiectasis (Telangiectasia)
11/2007 - 03/2004

Drug/Important Bio-Agent (IBA)

37Biological ProductsIBA
01/2022 - 04/2003
22Monoclonal AntibodiesIBA
12/2020 - 04/2004
19Adalimumab (Humira)FDA Link
12/2021 - 01/2007
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 09/2003
15Interleukin-17 (Interleukin 17)IBA
01/2022 - 12/2013
15Infliximab (Remicade)FDA Link
12/2021 - 01/2004
15efalizumab (Raptiva)FDA Link
06/2014 - 04/2003
14brodalumabIBA
06/2022 - 03/2012
14Ustekinumab (CNTO 1275)FDA Link
12/2021 - 02/2009
13Interleukin-12 (IL 12)IBA
06/2022 - 02/2008
13Interleukin-23 (Interleukin 23)IBA
12/2021 - 02/2009
11CytokinesIBA
04/2021 - 10/2004
10Etanercept (Enbrel)FDA Link
12/2021 - 03/2008
10secukinumabIBA
12/2021 - 12/2016
9InterleukinsIBA
06/2022 - 02/2009
8calcipotriene (calcipotriol)FDA LinkGeneric
10/2020 - 01/2009
8betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
10/2020 - 01/2009
7ixekizumabIBA
01/2022 - 08/2015
7Pharmaceutical PreparationsIBA
10/2021 - 02/2009
7Adrenal Cortex Hormones (Corticosteroids)IBA
02/2012 - 01/2002
6Biomarkers (Surrogate Marker)IBA
01/2020 - 04/2010
6Ointments (Pastes)IBA
01/2017 - 04/2007
6Methotrexate (Mexate)FDA LinkGeneric
05/2014 - 01/2002
6Clobetasol (Clobetasol Propionate)FDA LinkGeneric
02/2012 - 05/2002
6Alefacept (Amevive)FDA Link
10/2009 - 03/2003
5Interleukin-17 ReceptorsIBA
06/2022 - 03/2015
5Prostaglandins AIBA
10/2020 - 04/2004
5AerosolsIBA
06/2017 - 08/2016
4Biosimilar PharmaceuticalsIBA
01/2021 - 02/2012
4Immunoglobulin G (IgG)IBA
12/2020 - 01/2006
4Cyclosporine (Ciclosporin)FDA LinkGeneric
02/2015 - 01/2002
4Immunoglobulins (Immunoglobulin)IBA
10/2010 - 01/2003
3risankizumabIBA
12/2021 - 07/2015
3tildrakizumabIBA
12/2021 - 01/2020
3apremilastIBA
06/2020 - 08/2013
3Antirheumatic Agents (DMARD)IBA
01/2014 - 05/2008
3NF-kappa B (NF-kB)IBA
05/2012 - 02/2009
3SteroidsIBA
10/2011 - 05/2008
3Vitamin DFDA LinkGeneric
10/2011 - 01/2002
3Calcitriol (Calcijex)FDA LinkGeneric
10/2011 - 04/2007
3briakinumabIBA
08/2011 - 02/2008
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
06/2020 - 09/2009
2Tacrolimus (Prograf)FDA LinkGeneric
06/2020 - 09/2009
2Leflunomide (Arava)FDA LinkGeneric
06/2020 - 09/2009
2Thioguanine (Tioguanine)FDA Link
06/2020 - 09/2009
2FumaratesIBA
06/2020 - 09/2009
2tofacitinibIBA
06/2020 - 03/2014
2Hydroxyurea (Hydrea)FDA LinkGeneric
06/2020 - 09/2009
2Lipoproteins (Lipoprotein)IBA
01/2020 - 01/2018
2Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2020 - 01/2019
2dupilumabIBA
01/2020 - 01/2019
2CalciumIBA
04/2018 - 11/2016
2EsapentIBA
09/2017 - 09/2015
2P-2 (P 2)IBA
07/2015 - 03/2008
2Prednisone (Sone)FDA LinkGeneric
02/2015 - 01/2010
2omega-Chloroacetophenone (Mace)IBA
12/2014 - 08/2011
2Investigational DrugsIBA
04/2012 - 08/2011
2RetinoidsIBA
01/2009 - 01/2002
2Fluorouracil (Carac)FDA LinkGeneric
06/2008 - 08/2002
2Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2007 - 03/2004

Therapy/Procedure

71Therapeutics
06/2022 - 01/2002
28Biological Therapy
06/2022 - 03/2005
12Phototherapy (Light Therapy)
10/2019 - 01/2002
3Photochemotherapy (Photodynamic Therapy)
01/2010 - 07/2007
3Injections
10/2008 - 07/2007
2Excimer Lasers
09/2019 - 01/2010
2Subcutaneous Injections
01/2017 - 01/2010
2Retreatment
02/2011 - 03/2003